Endocrinology

Be the part of the global gathering for experts in obesity

Explore the modern medical research and application on diabetic condition & endocrinology function

This Program Will Consist Of Lecture, Small Group, Panel Discussion Formats Covering Best Practices, Barriers To Optimal Patient Outcomes And New Approaches To The Evaluation And Management Of Complex And Common Endocrine Disorders.

A premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Childhood Obesity and Nutrition.

Submit an education session proposal and have the unique opportunity to be part of the AACE 2024 annual meeting education program

The 22nd International Conference on Obesity, Diet Management & Nutrition covers topics such as: Genetic Obesity Current Research on Obesity Obesity- Health Risks Obesity and Cancer Bariatrics etc

FSREI 2024 Annual Meeting discuss the risks/benefits of surgery in different endometriosis phenotypes, discuss history and evolution of AI technologies in the IVF lab, research AI technologies for their potential and limitations for utilization in the IVF laboratory, summarize changing socio-demographics of postponing motherhood, discuss causes of ovarian aging and what can be done to efficiently stimulate aged ovaries, discuss the immediate and potential long-term impact of IVF practices.

Upon completion of the activity, participants should be better able to: Discuss the role of supplements in the therapeutic management of the person with diabetes; explain factors in the prevention and management of wounds in relation to the person with diabetes;

Participants will hear from pioneers in each of these areas, representing diverse perspectives and backgrounds. Potential workshops include: “New Horizons in Artificial Intelligence,” “Therapeutics for Healthy Aging,” and “The Regenerative Potential of Stem Cells in Aging”. This program is a unique opportunity to bring together leaders in the aging field from academia and industry who share the common goals of promoting healthy aging and combating age-associated disease.

This is a synergistic pairing, given that lipodystrophy has long been known to promote severe MAFLD and ways to reduce overall obesity are also being tried for MAFLD, such as with bariatric surgery and now GLP-1 and dual GLP-1/GIP agonists. Joint sessions on human genetics and therapeutics across MASH and obesity will facilitate interaction between endocrinologists, hepatologists, adipose and liver biologists for synergy